DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer

Biochemical and Biophysical Research Communications

Volumn 455, Issue 1-2, 2014, Pages 43-57

  Toiyama, Yuji ^a,b   Okugawa, Yoshinaga ^a,b   Goel, Ajay ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b MIE UNIVERSITY   (Japan)

Author keywords

Biomarker; Colorectal cancer; Diagnosis; Gastric cancer; Methylation; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; UNTRANSLATED RNA; TUMOR MARKER;

BLOOD; BODY FLUID; CANCER DIAGNOSIS; CANCER PATIENT; CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; GASTROINTESTINAL TRACT; HUMAN; REVIEW; STOMACH CANCER; STOMACH JUICE; CHEMISTRY; COLORECTAL NEOPLASMS; GENETIC EPIGENESIS; GENETICS; STOMACH NEOPLASMS;

BIOMARKERS, TUMOR; BODY FLUIDS; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; STOMACH NEOPLASMS;

EID: 84912088844     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.001     Document Type: Review

References (194)

1. P. Bertuccio, L. Chatenoud, F. Levi, D. Praud, J. Ferlay, E. Negri, M. Malvezzi, and C. La Vecchia Recent patterns in gastric cancer: a global overview Int. J. Cancer 125 2009 666 673
2. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2008 2893 2917
3. M.V. Iorio, and C.M. Croce MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review EMBO Mol. Med. 4 2012 143 159
4. S.L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard An operational definition of epigenetics Genes Dev. 23 2009 781 783
5. D. Rodenhiser, and M. Mann Epigenetics and human disease: translating basic biology into clinical applications CMAJ 174 2006 341 348
6. M. Ducasse, and M.A. Brown Epigenetic aberrations and cancer Mol Cancer 5 2006 60
7. R. Kanwal, and S. Gupta Epigenetics and cancer J. Appl. Physiol. 109 2010 1985 598 605
8. S.A. Belinsky Gene-promoter hypermethylation as a biomarker in lung cancer Nat. Rev. Cancer 4 2004 707 717
9. D. Deng, Z. Liu, and Y. Du Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers Adv. Genet. 71 2010 125 176
10. A. Hermann, H. Gowher, and A. Jeltsch Biochemistry and biology of mammalian DNA methyltransferases Cell. Mol. Life Sci. 61 2004 2571 2587
11. F.M. Selaru, S. David, S.J. Meltzer, and J.P. Hamilton Epigenetic events in gastrointestinal cancer Am. J. Gastroenterol. 104 2009 1910 1912
12. F. Gaudet, J.G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J.W. Gray, H. Leonhardt, and R. Jaenisch Induction of tumors in mice by genomic hypomethylation Science 300 2003 489 492
13. T. Yoshida, S. Yamashita, T. Takamura-Enya, T. Niwa, T. Ando, S. Enomoto, T. Maekita, K. Nakazawa, M. Tatematsu, M. Ichinose, and T. Ushijima Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae Int. J. Cancer 128 2011 33 39
14. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
15. A. Bird DNA methylation patterns and epigenetic memory Genes Dev. 16 2002 6 21
16. D. Jia, R.Z. Jurkowska, X. Zhang, A. Jeltsch, and X. Cheng Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation Nature 449 2007 248 251
17. D. Takai, and P.A. Jones Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Proc. Natl. Acad. Sci. USA 99 2002 3740 3745
18. I.J. van Vlodrop, H.E. Niessen, S. Derks, M.M. Baldewijns, W. van Criekinge, J.G. Herman, and M. van Engeland Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin. Cancer Res. 17 2011 4225 4231
19. M. Rodriguez-Paredes, and M. Esteller Cancer epigenetics reaches mainstream oncology Nat. Med. 17 2011 330 339
20. R. Singal, and G.D. Ginder DNA methylation Blood 93 1999 4059 4070
21. R. Singal, S.Z. Wang, T. Sargent, S.Z. Zhu, and G.D. Ginder Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex J. Biol. Chem. 277 2002 1897 1905
22. S.U. Kass, D. Pruss, and A.P. Wolffe How does DNA methylation repress transcription? Trends Genet. 13 1997 444 449
23. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
24. C.P. Walsh, J.R. Chaillet, and T.H. Bestor Transcription of IAP endogenous retroviruses is constrained by cytosine methylation Nat. Genet. 20 1998 116 117
25. M. Esteller, and G. Almouzni How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyond EMBO Rep. 6 2005 624 628
26. Y. Wang, and F.C. Leung An evaluation of new criteria for CpG islands in the human genome as gene markers Bioinformatics 20 2004 1170 1177
27. M.M. Suzuki, and A. Bird DNA methylation landscapes: provocative insights from epigenomics Nat. Rev. Genet. 9 2008 465 476
28. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification Acta Pathol. Microbiol. Scand. 64 1965 31 49
29. P. Correa, W. Haenszel, C. Cuello, S. Tannenbaum, and M. Archer A model for gastric cancer epidemiology Lancet 2 1975 58 60
30. B. Humar, and P. Guilford Hereditary diffuse gastric cancer: a manifestation of lost cell polarity Cancer Sci. 100 2009 1151 1157
31. C.O. Gigek, E.S. Chen, D.Q. Calcagno, F. Wisnieski, R.R. Burbano, and M.A. Smith Epigenetic mechanisms in gastric cancer Epigenomics 4 2012 279 294
32. A.C. Ferrasi, N.A. Pinheiro, S.H. Rabenhorst, O.L. Caballero, M.A. Rodrigues, F. de Carvalho, C.V. Leite, M.V. Ferreira, M.A. Barros, and M.I. Pardini Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability World J. Gastroenterol. 16 2010 312 319
33. D. Compare, A. Rocco, E. Liguori, F.P. D'Armiento, G. Persico, S. Masone, E. Coppola-Bottazzi, R. Suriani, M. Romano, and G. Nardone Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis J. Clin. Pathol. 64 2011 677 682
34. T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, M. Iguchi, K. Arii, A. Kaneda, T. Tsukamoto, M. Tatematsu, G. Tamura, D. Saito, T. Sugimura, M. Ichinose, and T. Ushijima High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin. Cancer Res. 12 2006 989 995
35. T. Ushijima, T. Nakajima, and T. Maekita DNA methylation as a marker for the past and future J. Gastroenterol. 41 2006 401 407
36. G. Nardone, D. Compare, P. De Colibus, G. de Nucci, and A. Rocco Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis Dig. Dis. 25 2007 225 229
37. E. Yamamoto, H. Suzuki, H. Takamaru, H. Yamamoto, M. Toyota, and Y. Shinomura Role of DNA methylation in the development of diffuse-type gastric cancer Digestion 83 2011 241 249
38. E.M. Lima, M.F. Leal, R.R. Burbano, A.S. Khayat, P.P. Assumpcao, M.J. Bello, J.A. Rey, M.A. Smith, and C. Casartelli Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer Braz. J. Med. Biol. Res. 41 2008 539 543
39. M.K. Alves, V.P. Lima, A.C. Ferrasi, M.A. Rodrigues, M.I. De Moura Campos Pardini, and S.H. Rabenhorst CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas APMIS 118 2010 297 307
40. A.O. Chan E-cadherin in gastric cancer World J. Gastroenterol. 12 2006 199 203
41. C.M. Shin, N. Kim, H.J. Yang, S.I. Cho, H.S. Lee, J.S. Kim, H.C. Jung, and I.S. Song Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer J. Clin. Gastroenterol. 44 2010 e34 39
42. T. Nakajima, S. Enomoto, S. Yamashita, T. Ando, Y. Nakanishi, K. Nakazawa, I. Oda, T. Gotoda, and T. Ushijima Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication J. Gastroenterol. 45 2010 37 44
43. C.M. Shin, N. Kim, J.H. Park, G.H. Kang, J.S. Kim, H.C. Jung, and I.S. Song Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae J. Pathol. 226 2012 654 665
44. G.H. Kang, Y.H. Shim, H.Y. Jung, W.H. Kim, J.Y. Ro, and M.G. Rhyu CpG island methylation in premalignant stages of gastric carcinoma Cancer Res. 61 2001 2847 2851
45. G.H. Kang, S. Lee, J.S. Kim, and H.Y. Jung Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis Lab. Invest. 83 2003 635 641
46. X.P. Zou, B. Zhang, X.Q. Zhang, M. Chen, J. Cao, and W.J. Liu Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions Hum. Pathol. 40 2009 1534 1542
47. Y.C. Wang, J.H. Xu, X. Geng, and W.M. Zhang Preliminary study on the alternative splicing pattern of human telomerase reverse transcriptase gene during gastric carcinogenesis Zhonghua Yi Xue Yi Chuan Xue Za Zhi 26 2009 151 155
48. Y.Y. Du, D.Q. Dai, and Z. Yang Role of RECK methylation in gastric cancer and its clinical significance World J. Gastroenterol. 16 2010 904 908
49. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
50. Z. Petko, M. Ghiassi, A. Shuber, J. Gorham, W. Smalley, M.K. Washington, S. Schultenover, S. Gautam, S.D. Markowitz, and W.M. Grady Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps Clin. Cancer Res. 11 2005 1203 1209
51. K. Yamashita, T. Dai, Y. Dai, F. Yamamoto, and M. Perucho Genetics supersedes epigenetics in colon cancer phenotype Cancer Cell 4 2003 121 131
52. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
53. A.P. Feinberg, and B. Vogelstein Hypomethylation of ras oncogenes in primary human cancers Biochem. Biophys. Res. Commun. 111 1983 47 54
54. V.V. Lao, and W.M. Grady Epigenetics and colorectal cancer Nat. Rev. Gastroenterol. Hepatol. 8 2011 686 700
55. F. Coppede Epigenetic biomarkers of colorectal cancer: focus on DNA methylation Cancer Lett. 342 2014 238 247
56. A. Goel, and C.R. Boland Epigenetics of colorectal cancer Gastroenterology 143 2012 1442 1460 (e1441)
57. L. Luo, W.D. Chen, and T.P. Pretlow CpG island methylation in aberrant crypt foci and cancers from the same patients Int. J. Cancer 115 2005 747 751
58. T.P. Pretlow, and T.G. Pretlow Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim. Biophys. Acta 1756 2005 83 96
59. M.M. Subramaniam, J.Y. Chan, R. Soong, K. Ito, K.G. Yeoh, R. Wong, T. Guenther, O. Will, C.L. Chen, M.P. Kumarasinghe, Y. Ito, and M. Salto-Tellez RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis Am. J. Gastroenterol. 104 2009 426 436
60. A.O. Chan, R.R. Broaddus, P.S. Houlihan, J.P. Issa, S.R. Hamilton, and A. Rashid CpG island methylation in aberrant crypt foci of the colorectum Am. J. Pathol. 160 2002 1823 1830
61. M.K. Wendt, P.A. Johanesen, N. Kang-Decker, D.G. Binion, V. Shah, and M.B. Dwinell Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis Oncogene 25 2006 4986 4997
62. N. Umetani, H. Takeuchi, A. Fujimoto, M. Shinozaki, A.J. Bilchik, and D.S. Hoon Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis Clin. Cancer Res. 10 2004 7475 7483
63. D. Yang, M. Thangaraju, K. Greeneltch, D.D. Browning, P.V. Schoenlein, T. Tamura, K. Ozato, V. Ganapathy, S.I. Abrams, and K. Liu Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells Cancer Res. 67 2007 3301 3309
64. N. Ahuja, and J.P. Issa Aging, methylation and cancer Histol. Histopathol. 15 2000 835 842
65. J.P. Issa, Y.L. Ottaviano, P. Celano, S.R. Hamilton, N.E. Davidson, and S.B. Baylin Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat. Genet. 7 1994 536 540
66. M. Toyota, and J.P. Issa CpG island methylator phenotypes in aging and cancer Semin. Cancer Biol. 9 1999 349 357
67. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
68. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, W.D. Chen, T.P. Pretlow, B. Yang, Y. Akiyama, M. Van Engeland, M. Toyota, T. Tokino, Y. Hinoda, K. Imai, J.G. Herman, and S.B. Baylin Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat. Genet. 36 2004 417 422
69. K. Kawakami, A. Ruszkiewicz, G. Bennett, J. Moore, F. Grieu, G. Watanabe, and B. Iacopetta DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer Br. J. Cancer 94 2006 593 598
70. M.L. Silviera, B.P. Smith, J. Powell, and C. Sapienza Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways Cancer Prev. Res. (Phila) 5 2012 374 384
71. K.P. Suijkerbuijk, P.J. van Diest, and E. van der Wall Improving early breast cancer detection: focus on methylation Ann. Oncol. 22 2011 24 29
72. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. USA 93 1996 9821 9826
73. M. Preusser, L. Elezi, and J.A. Hainfellner Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens Clin. Neuropathol. 27 2008 388 390
74. M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, M. Weller, J.M. Kros, J.A. Hainfellner, W. Mason, L. Mariani, J.E. Bromberg, P. Hau, R.O. Mirimanoff, J.G. Cairncross, R.C. Janzer, and R. Stupp MGMT gene silencing and benefit from temozolomide in glioblastoma N. Engl. J. Med. 352 2005 997 1003
75. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, C. Blake, D. Shibata, P.V. Danenberg, and P.W. Laird MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Res. 28 2000 E32
76. L.S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic Sensitive melting analysis after real time- methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection Nucleic Acids Res. 36 2008 e42
77. M. Li, W.D. Chen, N. Papadopoulos, S.N. Goodman, N.C. Bjerregaard, S. Laurberg, B. Levin, H. Juhl, N. Arber, H. Moinova, K. Durkee, K. Schmidt, Y. He, F. Diehl, V.E. Velculescu, S. Zhou, L.A. Diaz Jr., K.W. Kinzler, S.D. Markowitz, and B. Vogelstein Sensitive digital quantification of DNA methylation in clinical samples Nat. Biotechnol. 27 2009 858 863
78. J. Kagan, S. Srivastava, P.E. Barker, S.A. Belinsky, and P. Cairns Towards clinical application of methylated dna sequences as cancer biomarkers: a joint NCI's EDRN and NIST workshop on standards, methods, assays, reagents and tools Cancer Res. 67 2007 4545 4549
79. P. Hohenberger, and S. Gretschel Gastric cancer Lancet 362 2003 305 315
80. T.L. Lee, W.K. Leung, M.W. Chan, E.K. Ng, J.H. Tong, K.W. Lo, S.C. Chung, J.J. Sung, and K.F. To Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma Clin. Cancer Res. 8 2002 1761 1766
81. W.K. Leung, K.F. To, E.S. Chu, M.W. Chan, A.H. Bai, E.K. Ng, F.K. Chan, and J.J. Sung Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer Br. J. Cancer 92 2005 2190 2194
82. Y.Y. Cheng, J. Yu, Y.P. Wong, E.P. Man, K.F. To, V.X. Jin, J. Li, Q. Tao, J.J. Sung, F.K. Chan, and W.K. Leung Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer Br. J. Cancer 97 2007 895 901
83. Z. Chen, J.Q. Fan, J. Li, Q.S. Li, Z. Yan, X.K. Jia, W.D. Liu, L.J. Wei, F.Z. Zhang, H. Gao, J.P. Xu, X.M. Dong, J. Dai, and H.M. Zhou Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer Int. J. Cancer 124 2009 739 744
84. Y. Zhang, X. Ye, J. Geng, and L. Chen Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma Hepatogastroenterology 57 2010 1614 1619
85. Y. Zheng, L. Chen, J. Li, B. Yu, L. Su, X. Chen, Y. Yu, M. Yan, B. Liu, and Z. Zhu Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis Clin. Biochem. 44 2011 1405 1411
86. C. Bernal, F. Aguayo, C. Villarroel, M. Vargas, I. Diaz, F.J. Ossandon, E. Santibanez, M. Palma, E. Aravena, C. Barrientos, and A.H. Corvalan Reprimo as a potential biomarker for early detection in gastric cancer Clin. Cancer Res. 14 2008 6264 6269
87. W. Guo, Z. Dong, Y. Guo, Z. Chen, G. Kuang, and Z. Yang Aberrant methylation of the CpG island of HLTF gene in gastric cardia adenocarcinoma and dysplasia Clin. Biochem. 44 2011 784 788
88. E.K. Ng, C.P. Leung, V.Y. Shin, C.L. Wong, E.S. Ma, H.C. Jin, K.M. Chu, and A. Kwong Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients PLoS One 6 2011 e22233
89. S.C. Bae, and J.K. Choi Tumor suppressor activity of RUNX3 Oncogene 23 2004 4336 4340
90. Y. Zheng, Y. Zhang, X. Huang, and L. Chen Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients Hepatogastroenterology 58 2011 2007 2011
91. C. Sakakura, T. Hamada, K. Miyagawa, M. Nishio, A. Miyashita, H. Nagata, H. Ida, S. Yazumi, E. Otsuji, T. Chiba, K. Ito, and Y. Ito Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients Anticancer Res. 29 2009 2619 2625
92. Y.C. Wang, Z.H. Yu, C. Liu, L.Z. Xu, W. Yu, J. Lu, R.M. Zhu, G.L. Li, X.Y. Xia, X.W. Wei, H.Z. Ji, H. Lu, Y. Gao, W.M. Gao, and L.B. Chen Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients World J. Gastroenterol. 14 2008 3074 3080
93. F. Lombardo, F. De Luca, M. Rosano, C. Sferlazzas, C. Lucanto, T. Arrigo, M.F. Messina, G. Crisafulli, M. Wasniewska, M. Valenzise, and D. Cucinotta Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia Eur. J. Endocrinol. 149 2003 53 59
94. D. Ichikawa, H. Koike, H. Ikoma, D. Ikoma, N. Tani, E. Otsuji, K. Kitamura, and H. Yamagishi Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer Anticancer Res. 24 2004 2477 2481
95. M.R. Abbaszadegan, O. Moaven, H.R. Sima, K. Ghafarzadegan, A. A'Rabi, M.N. Forghani, H.R. Raziee, A. Mashhadinejad, M. Jafarzadeh, E. Esmaili-Shandiz, and E. Dadkhah P16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer World J. Gastroenterol. 14 2008 2055 2060
96. Y. Watanabe, H.S. Kim, R.J. Castoro, W. Chung, M.R. Estecio, K. Kondo, Y. Guo, S.S. Ahmed, M. Toyota, F. Itoh, K.T. Suk, M.Y. Cho, L. Shen, J. Jelinek, and J.P. Issa Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes Gastroenterology 136 2009 2149 2158
97. B. Levin Molecular screening testing for colorectal cancer Clin. Cancer Res. 12 2006 5014 5017
98. R.A. Smith, V. Cokkinides, D. Brooks, D. Saslow, and O.W. Brawley Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J. Clin. 60 2010 2010 99 119
99. D.A. Ahlquist, D.J. Sargent, C.L. Loprinzi, T.R. Levin, D.K. Rex, D.J. Ahnen, K. Knigge, M.P. Lance, L.J. Burgart, S.R. Hamilton, J.E. Allison, M.J. Lawson, M.E. Devens, J.J. Harrington, and S.L. Hillman Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann. Intern. Med. 149 2008 441 450 (W481)
100. P.J. Johnson, and Y.M. Lo Plasma nucleic acids in the diagnosis and management of malignant disease Clin. Chem. 48 2002 1186 1193
101. D. Sidransky Emerging molecular markers of cancer Nat. Rev. Cancer 2 2002 210 219
102. H.M. Muller, and M. Widschwendter Methylated DNA as a possible screening marker for neoplastic disease in several body fluids Expert Rev. Mol. Diagn. 3 2003 443 458
103. C. Lofton-Day, F. Model, T. Devos, R. Tetzner, J. Distler, M. Schuster, X. Song, R. Lesche, V. Liebenberg, M. Ebert, B. Molnar, R. Grutzmann, C. Pilarsky, and A. Sledziewski DNA methylation biomarkers for blood-based colorectal cancer screening Clin. Chem. 54 2008 414 423
104. T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, J. Distler, K.V. Steiger, R. Grutzmann, C. Pilarsky, J.K. Habermann, P.R. Fleshner, B.M. Oubre, R. Day, A.Z. Sledziewski, and C. Lofton-Day Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clin. Chem. 55 2009 1337 1346
105. R. Grutzmann, B. Molnar, C. Pilarsky, J.K. Habermann, P.M. Schlag, H.D. Saeger, S. Miehlke, T. Stolz, F. Model, U.J. Roblick, H.P. Bruch, R. Koch, V. Liebenberg, T. Devos, X. Song, R.H. Day, A.Z. Sledziewski, and C. Lofton-Day Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay PLoS One 3 2008 e3759
106. M. Tanzer, B. Balluff, J. Distler, K. Hale, A. Leodolter, C. Rocken, B. Molnar, R. Schmid, C. Lofton-Day, T. Schuster, and M.P. Ebert Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions PLoS One 5 2010 e9061
107. P.A. Kostin, N.B. Zakharzhevskaia, E.V. Generozov, V.M. Govorun, S.V. Chernyshov, and A. Shchelygin Iu Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer Vopr. Onkol. 56 2010 162 168
108. M.P. Ebert, F. Model, S. Mooney, K. Hale, J. Lograsso, L. Tonnes-Priddy, J. Hoffmann, A. Csepregi, C. Rocken, B. Molnar, H.U. Schulz, P. Malfertheiner, and C. Lofton-Day Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas Gastroenterology 131 2006 1418 1430
109. A. Herbst, K. Rahmig, P. Stieber, A. Philipp, A. Jung, A. Ofner, A. Crispin, J. Neumann, R. Lamerz, and F.T. Kolligs Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer Am. J. Gastroenterol. 106 2011 1110 1118
110. E. Cassinotti, J. Melson, T. Liggett, A. Melnikov, Q. Yi, C. Replogle, S. Mobarhan, L. Boni, S. Segato, and V. Levenson DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps Int. J. Cancer 131 2012 1153 1157
111. C.P. Lange, M. Campan, T. Hinoue, R.F. Schmitz, A.E. van der Meulen-de Jong, H. Slingerland, P.J. Kok, P.J. Kok, C.M. van Dijk, D.J. Weisenberger, H. Shen, H. Shen, R.A. Tollenaar, and P.W. Laird Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer PLoS One 7 2012 e50266
112. T.E. Skvortsova, E.Y. Rykova, S.N. Tamkovich, O.E. Bryzgunova, A.V. Starikov, N.P. Kuznetsova, V.V. Vlassov, and P.P. Laktionov Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation Br. J. Cancer 94 2006 1492 1495
113. M.O. Hoque, S. Begum, O. Topaloglu, C. Jeronimo, E. Mambo, W.H. Westra, J.A. Califano, and D. Sidransky Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer Cancer Res. 64 2004 5511 5517
114. M.O. Hoque, Q. Feng, P. Toure, A. Dem, C.W. Critchlow, S.E. Hawes, T. Wood, C. Jeronimo, E. Rosenbaum, J. Stern, M. Yu, B. Trink, N.B. Kiviat, and D. Sidransky Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer J. Clin. Oncol. 24 2006 4262 4269
115. T.R. Church, M. Wandell, C. Lofton-Day, S.J. Mongin, M. Burger, S.R. Payne, E. Castanos-Velez, B.A. Blumenstein, T. Rosch, N. Osborn, D. Snover, R.W. Day, and D.F. Ransohoff Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer Gut 63 2014 317 325
116. D.M. Hellebrekers, M.H. Lentjes, S.M. van den Bosch, V. Melotte, K.A. Wouters, K.L. Daenen, K.M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, C.A. Khalid-de Bakker, D. Jonkers, M.P. Weijenberg, J. Louwagie, W. van Criekinge, B. Carvalho, G.A. Meijer, S.B. Baylin, J.G. Herman, A.P. de Bruine, and M. van Engeland GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer Clin. Cancer Res. 15 2009 3990 3997
117. V. Melotte, M.H. Lentjes, S.M. van den Bosch, D.M. Hellebrekers, J.P. de Hoon, K.A. Wouters, K.L. Daenen, I.E. Partouns-Hendriks, F. Stessels, J. Louwagie, K.M. Smits, M.P. Weijenberg, S. Sanduleanu, C.A. Khalid-de Bakker, F.A. Oort, G.A. Meijer, D.M. Jonkers, J.G. Herman, A.P. de Bruine, and M. van Engeland N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J. Natl. Cancer Inst. 101 2009 916 927
118. M.S. Kim, J. Louwagie, B. Carvalho, J.S. Terhaar Sive Droste, H.L. Park, Y.K. Chae, K. Yamashita, J. Liu, K.L. Ostrow, S. Ling, R. Guerrero-Preston, S. Demokan, Z. Yalniz, N. Dalay, G.A. Meijer, W. Van Criekinge, and D. Sidransky Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer PLoS One 4 2009 e6555
119. Q. Guo, Y. Song, H. Zhang, X. Wu, P. Xia, and C. Dang Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients Med. Oncol. 30 2013 695
120. T. Nagasaka, N. Tanaka, H.M. Cullings, D.S. Sun, H. Sasamoto, T. Uchida, M. Koi, N. Nishida, Y. Naomoto, C.R. Boland, N. Matsubara, and A. Goel Analysis of fecal DNA methylation to detect gastrointestinal neoplasia J. Natl. Cancer Inst. 101 2009 1244 1258
121. Y.X. Luo, D.K. Chen, S.X. Song, L. Wang, and J.P. Wang Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis Int. J. Clin. Pract. 65 2011 1313 1320
122. H. Yang, B.Q. Xia, B. Jiang, G. Wang, Y.P. Yang, H. Chen, B.S. Li, A.G. Xu, Y.B. Huang, and X.Y. Wang Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis Can. J. Gastroenterol. 27 2013 467 475
123. S.H. Itzkowitz, L. Jandorf, R. Brand, L. Rabeneck, P.C. Schroy 3rd, S. Sontag, D. Johnson, J. Skoletsky, K. Durkee, S. Markowitz, and A. Shuber Improved fecal DNA test for colorectal cancer screening Clin. Gastroenterol. Hepatol. 5 2007 111 117
124. S. Itzkowitz, R. Brand, L. Jandorf, K. Durkee, J. Millholland, L. Rabeneck, P.C. Schroy 3rd, S. Sontag, D. Johnson, S. Markowitz, L. Paszat, and B.M. Berger A simplified, noninvasive stool DNA test for colorectal cancer detection Am. J. Gastroenterol. 103 2008 2862 2870
125. J.S. Mattick The genetic signatures of noncoding RNAs PLoS Genet. 5 2009 e1000459
126. S.R. Eddy Non-coding RNA genes and the modern RNA world Nat Rev Genet 2 2001 919 929
127. S. Djebali, C.A. Davis, A. Merkel, A. Dobin, T. Lassmann, A. Mortazavi, A. Tanzer, J. Lagarde, W. Lin, F. Schlesinger, C. Xue, G.K. Marinov, J. Khatun, B.A. Williams, C. Zaleski, J. Rozowsky, M. Roder, F. Kokocinski, R.F. Abdelhamid, T. Alioto, I. Antoshechkin, M.T. Baer, N.S. Bar, P. Batut, K. Bell, I. Bell, S. Chakrabortty, X. Chen, J. Chrast, J. Curado, T. Derrien, J. Drenkow, E. Dumais, J. Dumais, R. Duttagupta, E. Falconnet, M. Fastuca, K. Fejes-Toth, P. Ferreira, S. Foissac, M.J. Fullwood, H. Gao, D. Gonzalez, A. Gordon, H. Gunawardena, C. Howald, S. Jha, R. Johnson, P. Kapranov, B. King, C. Kingswood, O.J. Luo, E. Park, K. Persaud, J.B. Preall, P. Ribeca, B. Risk, D. Robyr, M. Sammeth, L. Schaffer, L.H. See, A. Shahab, J. Skancke, A.M. Suzuki, H. Takahashi, H. Tilgner, D. Trout, N. Walters, H. Wang, J. Wrobel, Y. Yu, X. Ruan, Y. Hayashizaki, J. Harrow, M. Gerstein, T. Hubbard, A. Reymond, S.E. Antonarakis, G. Hannon, M.C. Giddings, Y. Ruan, B. Wold, P. Carninci, R. Guigo, and T.R. Gingeras Landscape of transcription in human cells Nature 489 2012 101 108
128. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl Identification of novel genes coding for small expressed RNAs Science 294 2001 853 858
129. R.J. Taft, K.C. Pang, T.R. Mercer, M. Dinger, and J.S. Mattick Non-coding RNAs: regulators of disease J. Pathol. 220 2010 126 139
130. M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, and G.A. Calin MicroRNAs in body fluids-the mix of hormones and biomarkers Nat. Rev. Clin. Oncol. 8 2011 467 477
131. T.R. Mercer, M.E. Dinger, and J.S. Mattick Long non-coding RNAs: insights into functions Nat. Rev. Genet. 10 2009 155 159
132. J.L. Rinn, and H.Y. Chang Genome regulation by long noncoding RNAs Annu. Rev. Biochem. 81 2012 145 166
133. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, and M. Tewari Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. USA 105 2008 10513 10518
134. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, K. Zen, and C.Y. Zhang Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res. 18 2008 997 1006
135. W. Zhu, W. Qin, U. Atasoy, and E.R. Sauter Circulating microRNAs in breast cancer and healthy subjects BMC Res. Notes 2 2009 89
136. M. Fabbri MiRNAs as molecular biomarkers of cancer Expert Rev. Mol. Diagn. 10 2010 435 444
137. X. Chen, H. Liang, J. Zhang, K. Zen, and C.Y. Zhang Secreted microRNAs: a new form of intercellular communication Trends Cell Biol. 22 2012 125 132
138. E.R. Mardis The impact of next-generation sequencing technology on genetics Trends Genet. 24 2008 133 141
139. M.L. Metzker Sequencing technologies - the next generation Nat. Rev. Genet. 11 2010 31 46
140. M. Baker MicroRNA profiling: separating signal from noise Nat. Methods 7 2010 687 692
141. C.C. Pritchard, E. Kroh, B. Wood, J.D. Arroyo, K.J. Dougherty, M.M. Miyaji, J.F. Tait, and M. Tewari Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies Cancer Prev. Res. (Phila) 5 2012 492 497
142. J.S. McDonald, D. Milosevic, H.V. Reddi, S.K. Grebe, and A. Algeciras-Schimnich Analysis of circulating microRNA: preanalytical and analytical challenges Clin. Chem. 57 2011 833 840
143. M.B. Kirschner, S.C. Kao, J.J. Edelman, N.J. Armstrong, M.P. Vallely, N. van Zandwijk, and G. Reid Haemolysis during sample preparation alters microRNA content of plasma PLoS One 6 2011 e24145
144. Y. Ma, X. Wang, and H. Jin Methylated DNA and microRNA in body fluids as biomarkers for cancer detection Int. J. Mol. Sci. 14 2013 10307 10331
145. F. Wang, G.P. Sun, Y.F. Zou, J.Q. Hao, F. Zhong, and W.J. Ren MicroRNAs as promising biomarkers for gastric cancer Cancer Biomark 11 2012 259 267
146. M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, T. Kosuga, H. Konishi, R. Morimura, K. Deguchi, H. Fujiwara, K. Okamoto, and E. Otsuji Circulating microRNAs in plasma of patients with gastric cancers Br. J. Cancer 102 2010 1174 1179
147. R. Liu, C. Zhang, Z. Hu, G. Li, C. Wang, C. Yang, D. Huang, X. Chen, H. Zhang, R. Zhuang, T. Deng, H. Liu, J. Yin, S. Wang, K. Zen, Y. Ba, and C.Y. Zhang A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis Eur. J. Cancer 47 2011 784 791
148. H. Liu, L. Zhu, B. Liu, L. Yang, X. Meng, W. Zhang, Y. Ma, and H. Xiao Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer Cancer Lett. 316 2012 196 203
149. M.Y. Song, K.F. Pan, H.J. Su, L. Zhang, J.L. Ma, J.Y. Li, Y. Yuasa, D. Kang, Y.S. Kim, and W.C. You Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer PLoS One 7 2012 e33608
150. H. Konishi, D. Ichikawa, S. Komatsu, A. Shiozaki, M. Tsujiura, H. Takeshita, R. Morimura, H. Nagata, T. Arita, T. Kawaguchi, S. Hirashima, H. Fujiwara, K. Okamoto, and E. Otsuji Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma Br. J. Cancer 106 2012 740 747
151. B.S. Li, Y.L. Zhao, G. Guo, W. Li, E.D. Zhu, X. Luo, X.H. Mao, Q.M. Zou, P.W. Yu, Q.F. Zuo, N. Li, B. Tang, K.Y. Liu, and B. Xiao Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection PLoS One 7 2012 e41629
152. H. Cai, Y. Yuan, Y.F. Hao, T.K. Guo, X. Wei, and Y.M. Zhang Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer Med. Oncol. 30 2013 452
153. C. Li, J.F. Li, Q. Cai, Q.Q. Qiu, M. Yan, B.Y. Liu, and Z.G. Zhu MiRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer Ann. Surg. Oncol. 20 Suppl 3 2013 S397 405
154. M. Wang, H. Gu, S. Wang, H. Qian, W. Zhu, L. Zhang, C. Zhao, Y. Tao, and W. Xu Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer Mol. Med. Rep. 5 2012 1514 1520
155. S. Komatsu, D. Ichikawa, M. Tsujiura, H. Konishi, H. Takeshita, H. Nagata, T. Kawaguchi, S. Hirajima, T. Arita, A. Shiozaki, T. Kubota, H. Fujiwara, K. Okamoto, and E. Otsuji Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma Anticancer Res. 33 2013 271 276
156. K.W. Tsai, Y.L. Liao, C.W. Wu, L.Y. Hu, S.C. Li, W.C. Chan, M.R. Ho, C.H. Lai, H.W. Kao, W.L. Fang, K.H. Huang, and W.C. Lin Aberrant expression of miR-196a in gastric cancers and correlation with recurrence Genes Chromosomes Cancer 51 2012 394 401
157. X. Zhang, L. Cui, G. Ye, T. Zheng, H. Song, T. Xia, X. Yu, B. Xiao, Y. Le, and J. Guo Gastric juice microRNA-421 is a new biomarker for screening gastric cancer Tumour Biol. 33 2012 2349 2355
158. X. Yu, L. Luo, Y. Wu, Y. Liu, X. Zhao, X. Zhang, L. Cui, G. Ye, Y. Le, and J. Guo Gastric juice miR-129 as a potential biomarker for screening gastric cancer Med. Oncol. 30 2013 365
159. L. Cui, X. Zhang, G. Ye, T. Zheng, H. Song, H. Deng, B. Xiao, T. Xia, X. Yu, Y. Le, and J. Guo Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer Cancer 119 2013 1618 1626
160. M.J. Lodes, M. Caraballo, D. Suciu, S. Munro, A. Kumar, and B. Anderson Detection of cancer with serum miRNAs on an oligonucleotide microarray PLoS One 4 2009 e6229
161. E.K. Ng, W.W. Chong, H. Jin, E.K. Lam, V.Y. Shin, J. Yu, T.C. Poon, S.S. Ng, and J.J. Sung Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
162. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int. J. Cancer 127 2010 118 126
163. L.G. Wang, and J. Gu Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis Cancer Epidemiol. 36 2012 e61 67
164. M.D. Giraldez, J.J. Lozano, G. Ramirez, E. Hijona, L. Bujanda, A. Castells, and M. Gironella Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Clin. Gastroenterol. Hepatol. 11 2013 681 688 (e683)
165. Q. Wang, Z. Huang, S. Ni, X. Xiao, Q. Xu, L. Wang, D. Huang, C. Tan, W. Sheng, and X. Du Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer PLoS One 7 2012 e44398
166. I.A. Asangani, S.A. Rasheed, D.A. Nikolova, J.H. Leupold, N.H. Colburn, S. Post, and H. Allgayer MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2008 2128 2136
167. P. Wang, F. Zou, X. Zhang, H. Li, A. Dulak, R.J. Tomko Jr., J.S. Lazo, Z. Wang, L. Zhang, and J. Yu MicroRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells Cancer Res. 69 2009 8157 8165
168. Z. Kanaan, S.N. Rai, M.R. Eichenberger, H. Roberts, B. Keskey, J. Pan, and S. Galandiuk Plasma miR-21: a potential diagnostic marker of colorectal cancer Ann. Surg. 256 2012 544 551
169. G.H. Liu, Z.G. Zhou, R. Chen, M.J. Wang, B. Zhou, Y. Li, and X.F. Sun Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer Tumour Biol. 34 2013 2175 2181
170. Y. Toiyama, M. Takahashi, K. Hur, T. Nagasaka, K. Tanaka, Y. Inoue, M. Kusunoki, C.R. Boland, and A. Goel Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer J. Natl. Cancer Inst. 105 2013 849 859
171. A. Baraniskin, S. Nopel-Dunnebacke, M. Ahrens, S.G. Jensen, H. Zollner, A. Maghnouj, A. Wos, J. Mayerle, J. Munding, D. Kost, A. Reinacher-Schick, S. Liffers, R. Schroers, A.M. Chromik, H.E. Meyer, W. Uhl, S. Klein-Scory, F.U. Weiss, C. Stephan, I. Schwarte-Waldhoff, M.M. Lerch, A. Tannapfel, W. Schmiegel, C.L. Andersen, and S.A. Hahn Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma Int. J. Cancer 132 2013 E48 57
172. H. Cheng, L. Zhang, D.E. Cogdell, H. Zheng, A.J. Schetter, M. Nykter, C.C. Harris, K. Chen, S.R. Hamilton, and W. Zhang Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis PLoS One 6 2011 e17745
173. Y. Toiyama, K. Hur, K. Tanaka, Y. Inoue, M. Kusunoki, C.R. Boland, and A. Goel Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer Ann. Surg. 2013
174. P. Menendez, D. Padilla, P. Villarejo, T. Palomino, P. Nieto, J.M. Menendez, and J.A. Rodriguez-Montes Prognostic implications of serum microRNA-21 in colorectal cancer J. Surg. Oncol. 108 2013 369 373
175. X.X. Pu, G.L. Huang, H.Q. Guo, C.C. Guo, H. Li, S. Ye, S. Ling, L. Jiang, Y. Tian, and T.Y. Lin Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression J. Gastroenterol. Hepatol. 25 2011 1674 1680
176. F.E. Ahmed, C.D. Jeffries, P.W. Vos, G. Flake, G.J. Nuovo, D.R. Sinar, W. Naziri, and S.P. Marcuard Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue Cancer Genomics Proteomics 6 2009 281 295
177. A. Link, F. Balaguer, Y. Shen, T. Nagasaka, J.J. Lozano, C.R. Boland, and A. Goel Fecal MicroRNAs as novel biomarkers for colon cancer screening Cancer Epidemiol. Biomarkers Prev. 19 2010 1766 1774
178. Y. Koga, M. Yasunaga, A. Takahashi, J. Kuroda, Y. Moriya, T. Akasu, S. Fujita, S. Yamamoto, H. Baba, and Y. Matsumura MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening Cancer Prev. Res. (Phila) 3 2010 1435 1442
179. C.W. Wu, S.S. Ng, Y.J. Dong, S.C. Ng, W.W. Leung, C.W. Lee, Y.N. Wong, F.K. Chan, J. Yu, and J.J. Sung Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps Gut 61 2012 739 745
180. M. Kalimutho, G. Del Vecchio Blanco, S. Di Cecilia, P. Sileri, M. Cretella, F. Pallone, G. Federici, and S. Bernardini Differential expression of miR-144∗ as a novel fecal-based diagnostic marker for colorectal cancer J. Gastroenterol. 46 2011 1391 1402
181. W.C. Cho Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis Front. Genet. 2 2011 7
182. R. Radpour, Z. Barekati, C. Kohler, Q. Lv, N. Burki, C. Diesch, J. Bitzer, H. Zheng, S. Schmid, and X.Y. Zhong Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer PLoS One 6 2011 e16080
183. C.M. Sturgeon, B.R. Hoffman, D.W. Chan, S.L. Ch'ng, E. Hammond, D.F. Hayes, L.A. Liotta, E.F. Petricoin, M. Schmitt, O.J. Semmes, G. Soletormos, E. van der Merwe, and E.P. Diamandis National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements Clin. Chem. 54 2008 e1 e10
184. S.U. Meyer, M.W. Pfaffl, and S.E. Ulbrich Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity? Biotechnol. Lett. 32 2010 1777 1788
185. Y. Kanyama, K. Hibi, H. Nakayama, Y. Kodera, K. Ito, S. Akiyama, and A. Nakao Detection of p16 promoter hypermethylation in serum of gastric cancer patients Cancer Sci. 94 2003 418 420
186. K. Hibi, T. Goto, A. Shirahata, M. Saito, G. Kigawa, H. Nemoto, and Y. Sanada Detection of TFPI2 methylation in the serum of gastric cancer patients Anticancer Res. 31 2011 3835 3838
187. P. Muretto, A. Ruzzo, F. Pizzagalli, F. Graziano, P. Maltese, C. Zingaretti, E. Berselli, N. Donnarumma, and M. Magnani Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients Ann. Oncol. 19 2008 516 519
188. B.B. Lee, E.J. Lee, E.H. Jung, H.K. Chun, D.K. Chang, S.Y. Song, J. Park, and D.H. Kim Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer Clin. Cancer Res. 15 2009 6185 6191
189. K. Lenhard, G.T. Bommer, S. Asutay, R. Schauer, T. Brabletz, B. Goke, R. Lamerz, and F.T. Kolligs Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer Clin. Gastroenterol. Hepatol. 3 2005 142 149
190. C. Ausch, Y.H. Kim, K.D. Tsuchiya, S. Dzieciatkowski, M.K. Washington, C. Paraskeva, J. Radich, and W.M. Grady Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA Clin. Chem. 55 2009 1559 1563
191. H.M. Muller, M. Oberwalder, H. Fiegl, M. Morandell, G. Goebel, M. Zitt, M. Muhlthaler, D. Ofner, R. Margreiter, and M. Widschwendter Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363 2004 1283 1285
192. W.D. Chen, Z.J. Han, J. Skoletsky, J. Olson, J. Sah, L. Myeroff, P. Platzer, S. Lu, D. Dawson, J. Willis, T.P. Pretlow, J. Lutterbaugh, L. Kasturi, J.K. Willson, J.S. Rao, A. Shuber, and S.D. Markowitz Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene J. Natl. Cancer Inst. 97 2005 1124 1132
193. A. Brunet Vega, C. Pericay, I. Moya, A. Ferrer, E. Dotor, A. Pisa, A. Casalots, X. Serra-Aracil, J.C. Oliva, A. Ruiz, and E. Saigi microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers Oncol. Rep. 30 2013 320 326
194. Y. Koga, N. Yamazaki, Y. Yamamoto, S. Yamamoto, N. Saito, Y. Kakugawa, Y. Otake, M. Matsumoto, and Y. Matsumura Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test Cancer Epidemiol. Biomarkers Prev. 22 2013 1844 1852